These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8429281)

  • 21. Association of obesity and distribution of obesity with glucose tolerance and cardiovascular risk factors in the elderly.
    Mykkänen L; Laakso M; Pyörälä K
    Int J Obes Relat Metab Disord; 1992 Sep; 16(9):695-704. PubMed ID: 1328093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2).
    Dixon JB; O'Brien P
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):793-7. PubMed ID: 11439291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic and metabolic profile in offspring of malignant hypertensive parents.
    Lopes HF; Bortolotto LA; Szlejf C; Kamitsuji CS; Krieger EM
    Hypertension; 2001 Sep; 38(3 Pt 2):616-20. PubMed ID: 11566942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.
    Lambert E; Straznicky N; Eikelis N; Esler M; Dawood T; Masuo K; Schlaich M; Lambert G
    J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
    Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamics, plasma noradrenaline and plasma renin in hypertensive and normotensive teenagers.
    Hofman A; Roelandt JT; Boomsma F; Schalekamp MA; Valkenburg HA
    Clin Sci (Lond); 1981 Aug; 61(2):169-74. PubMed ID: 7021039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum insulin level versus blood pressure: a cross-sectional, case-controlled study in non-obese, middle-aged Japanese subjects with normal glucose tolerance.
    Baba T; Kodama T; Tomiyama T; Sohn DR; Ishizaki T
    Diabet Med; 1994; 11(1):42-9. PubMed ID: 8181251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-term study of plasma catecholamine levels and plasma renin activity in borderline hypertension.
    Böhm RO; van Baak MA; van Hooff ME; Mooy J; Rahn KH
    J Hypertens; 1987 Dec; 5(6):655-61. PubMed ID: 3323317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of serum insulin levels in patients of euglycemic essential hypertension: a cross sectional study in North Indian population.
    Singla R; Goyal A; Bedi GK; Rao HK
    Diabetes Metab Syndr; 2013; 7(4):202-5. PubMed ID: 24290084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension.
    Schillaci G; Vaudo G; Reboldi G; Verdecchia P; Lupattelli G; Pasqualini L; Porcellati C; Mannarino E
    J Hypertens; 2001 Dec; 19(12):2265-70. PubMed ID: 11725172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study.
    Petkeviciene J; Klumbiene J; Kriaucioniene V; Raskiliene A; Sakyte E; Ceponiene I
    BMC Public Health; 2015 Mar; 15():218. PubMed ID: 25880559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis.
    Andrade DO; Santos SPO; Pinhel MAS; Valente FM; Giannini MC; Gregório ML; De Godoy MF; Souza DRS; Vilela-Martin JF
    Clin Exp Hypertens; 2017; 39(6):553-561. PubMed ID: 28569557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing roles of body mass and the renin-angiotensin system in mediating the hypertension syndrome.
    Weber MA; Smith DH; Neutel JM
    Am J Nephrol; 2000; 20(3):169-74. PubMed ID: 10878396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men.
    Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Møller DV; Hedley PL; Christiansen M; Goetze JP; Esler M; Jeppesen JL
    Hypertension; 2013 Jul; 62(1):147-53. PubMed ID: 23670298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls.
    Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH
    Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.
    Ferrari P; Weidmann P; Shaw S; Giachino D; Riesen W; Allemann Y; Heynen G
    Am J Med; 1991 Dec; 91(6):589-96. PubMed ID: 1750428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlations between blood pressure, blood volume, plasma renin and urinary catecholamines in normal subjects and in patients with benign essential hypertension].
    Weidmann P; Hirsch D; Beretta-Piccoli C; Reubi FC; Ziegler WH
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1741-3. PubMed ID: 1013697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.